Sustained long-term immune responses after in situ gene therapy combined with radiotherapy and hormonal therapy in prostate cancer patients

Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer

Daniel P. Petrylak, Catherine M. Tangen, Maha Hussain et al. · New England Journal of Medicine · 2004 · 3.7K citations · Full text

Pharmacy, Oncology, Pharmacotherapy +13

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

M. Bolla, Laurence Collette, L.E.C.M. Blank et al. · The Lancet · 2002 · 1.7K citations

Medicine, Oncology, Urology +17

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

M. Bolla, Dionisio González, Padraig Warde et al. · New England Journal of Medicine · 1997 · 1.6K citations · Full text

Medicine, Oncology, Urology +15

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

Alan Pollack, Gunar K. Zagars, George Starkschall et al. · International Journal of Radiation Oncology*Biology*Physics · 2002 · 1.3K citations

Medicine, Oncology, Radiation Oncology +14

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma—long-term results of phase III RTOG 85–31

Miljenko V. Pilepich, Kathryn Winter, C.A. Lawton et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 920 citations

Medicine, Oncology, Urology +16